NewsRx

Search our medical news database

Conference Coverage (IBC Protease Inhibitors)

Ritonavir Combinations Shine in Early Studies

Published in AIDS Weekly, July 8th, 1996

Ritonavir, Abbott's entry in the HIV protease-inhibitor sweepstakes, is highly effective in combination with other anti-HIV drugs.

The data described by senior Abbott researcher Akhter Molla is expected to be released during the July 1996 XI International Conference on AIDS in Vancouver, Canada.

Molla said that the combination of ritonavir with the less potent protease inhibitor saquinavir (Invirase, Roche) "holds great promise."

Molla described the studies during a presentation to the International Business Communications (IBC) workshop "HIV Protease Inhibitors," held June 11, 1996 in San Francisco, California.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook